IFCC Working Group Recommendations for Assessing Commutability Part 2: Using the Difference in Bias between a Reference Material and Clinical Samples

被引:103
作者
Nilsson, Goran
Budd, Jeffrey R. [1 ]
Greenberg, Neil [2 ]
Delatour, Vincent [3 ]
Rej, Robert [4 ,5 ]
Panteghini, Mauro [6 ]
Ceriotti, Ferruccio [7 ]
Schimmel, Heinz [8 ]
Weykamp, Cas [9 ]
Keller, Thomas [10 ]
Camara, Johanna E. [11 ]
Burns, Chris [12 ]
Vesper, Hubert W. [13 ]
MacKenzie, Finlay [14 ]
Miller, W. Greg [15 ]
机构
[1] Beckman Coulter, Chaska, MN USA
[2] Neil Greenberg Consulting LLC, Rochester, NY USA
[3] Lab Natl Metrol & Essais LNE, Paris, France
[4] SUNY Albany, New York State Dept Hlth, Wadsworth Ctr Labs & Res, Albany, NY 12222 USA
[5] SUNY Albany, Sch Publ Hlth, Albany, NY USA
[6] Univ Milan, Res Ctr Metrol Traceabil Lab Med CIRME, Milan, Italy
[7] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
[8] European Commiss, JRC, Directorate F, Geel, Belgium
[9] Queen Beatrix Hosp, Winterswijk, Netherlands
[10] ACOMED Stat, Leipzig, Germany
[11] NIST, Gaithersburg, MD 20899 USA
[12] Natl Inst Biol Stand & Controls, Ridge, Herts, England
[13] Ctr Dis Control & Prevent, Atlanta, GA USA
[14] Univ Hosp Birmingham NHS Fdn Trust, Birmingham Qual UK NEQAS, Birmingham, W Midlands, England
[15] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA
关键词
D O I
10.1373/clinchem.2017.277541
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
A process is described to assess the commutability of a reference material (RM) intended for use as a calibrator, trueness control, or external quality assessment sample based on the difference in bias between an RM and clinical samples (CSs) measured using 2 different measurement procedures (MPs). This difference in bias is compared with a criterion based on a medically relevant difference between an RM and CS results to make a conclusion regarding commutability. When more than 2 MPs are included, the commutability is assessed pairwise for all combinations of 2 MPs. This approach allows the same criterion to be used for all combinations of MPs included in the assessment. The assessment is based on an error model that allows estimation of various random and systematic sources of error, including those from sample-specific effects of interfering substances. An advantage of this approach is that the difference in bias between an RM and the average bias of CSs at the concentration (i.e., amount of substance present or quantity value) of the RM is determined and its uncertainty estimated. An RM is considered fit for purpose for those MPs for which commutability is demonstrated. (c) 2017 American Association for Clinical Chemistry
引用
收藏
页码:455 / 464
页数:10
相关论文
共 7 条
[1]  
[Anonymous], 1952, Statistical Theory with Engineering Applications
[2]  
[Anonymous], 2010, Document EP30-A (formerly C53-A)
[3]  
[Anonymous], EV MEAS DAT GUID EXP
[4]  
Clinical Laboratory Standards Institute, 2014, EP14A3 CLSI
[5]   IFCC Working Group Recommendations for Assessing Commutability Part 1: General Experimental Design [J].
Miller, W. Greg ;
Schimmel, Heinz ;
Rej, Robert ;
Greenberg, Neil ;
Ceriotti, Ferruccio ;
Burns, Chris ;
Budd, Jeffrey R. ;
Weykamp, Cas ;
Delatour, Vincent ;
Nilsson, Goeran ;
MacKenzie, Finlay ;
Panteghini, Mauro ;
Keller, Thomas ;
Camara, Johanna E. ;
Zegers, Ingrid ;
Vesper, Hubert W. .
CLINICAL CHEMISTRY, 2018, 64 (03) :447-454
[6]   Toward Standardization of Insulin Immunoassays [J].
Miller, W. Greg ;
Thienpont, Linda M. ;
Van Uytfanghe, Katleen ;
Clark, Penelope M. ;
Lindstedt, Patrik ;
Nilsson, Goran ;
Steffes, Michael W. .
CLINICAL CHEMISTRY, 2009, 55 (05) :1011-1018
[7]   COMPARISON OF MEASUREMENT METHODS BASED ON A MODEL FOR THE ERROR STRUCTURE [J].
NILSSON, G .
JOURNAL OF CHEMOMETRICS, 1991, 5 (06) :523-536